Showing results (41-50 of 127) with videos related to
Sort By:
Pageof 13
Multiple Sclerosis and Related Disorders|September 27, 2020
Is benign MS really benign? What a meaningful classification beyond the EDSS must take into considerationDavid Ellenberger, Peter Flachenecker, Judith Haas, et al.Expert Review of Neurotherapeutics|March 25, 2015
Dimethyl fumarate in relapsing-remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safetyDuvyanshu Dubey, Bernd C Kieseier, Hans P Hartung, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2020
High-intensity interval training reduces neutrophil-to-lymphocyte ratio in persons with multiple sclerosis during inpatient rehabilitationNiklas Joisten, Sebastian Proschinger, Annette Rademacher, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 8, 2025
Paediatric-onset multiple sclerosis: demographics, symptoms and disease progressionDavid Ellenberger, Peter Flachenecker, Judith Haas, et al.Neurology|July 24, 2023
Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to TherapyFinja Schweitzer, Sarah Laurent, Irene Cortese, et al.Frontiers in Neurology|August 16, 2023
Physical activity is related to disease severity and fatigue, but not to relapse rate in persons with relapsing remitting multiple sclerosis - a self-reported questionnaire based studyMarit L Schlagheck, Sven T Hübner, Niklas Joisten, et al.Journal of Neurology|September 4, 2025
Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosisDavid Ellenberger, Niklas Frahm, Alexander Stahmann, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRISMike P Wattjes, Martijn T Wijburg, Jeroen van Eijk, et al.Multiple Sclerosis and Related Disorders|May 12, 2024
Absence of JC polyomavirus in stool samples of patients with multiple sclerosis despite high anti-JCV antibodies in serumFinja Schweitzer, Anne Ladwig, Sarah Opala, et al.Plos One|October 16, 2019
EMR-integrated minimal core dataset for routine health care and multiple research settings: A case study for neuroinflammatory demyelinating diseasesSophia von Martial, Tobias J Brix, Luisa Klotz, et al.Pageof 13